Abstract: The invention provides compounds of general formula (D wherein m, n, Q, Z1, Z2, R1, R2, R3, R4, R5, R6, R7, and R8 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: An overvoltage protector circuit for telecommunication equipments is disclosed. The protector circuit includes a gas discharge tube connected to a communication line for passing any harmful surge currents appearing in the line to ground. A degradation detector circuit is arranged to detect any degradation of the gas discharge tube, the detector circuit comprises a reference gas discharge tube with a higher breakdown voltage than the supervised gas discharge tube and an alarm circuit loop connected to an alarm system. The alarm system is arranged to detect when current is breaking through the reference gas discharge tube and to initiate a degradation alarm.

Abstract: Compounds of formula (I) wherein R1, R3, R4, R5, R6, R7, and R10 are as defined in the specification, are described. The present invention also relates to pharmaceutical composition comprising said compounds and to the use of said compounds in therapy. The present invention further relates to processes for the preparation of said compounds and to new intermediates useful in the preparation thereof. Beside, the invention relates to salts and polymorphic forms of the new compounds as well as the preparation thereof.

Abstract: The invention provides compounds of general formula (I) wherein A, X, m, R1, N, R2, Z1, Z2, Q, R3, R4, R5, R6, R7, R8, t and R16 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy

Abstract: The invention provides compounds of general formula (I), wherein R1, X, Y, n, R2, Z1, Z2, A1, A2, Q, R3, R4, R5, R6, R7, R8, t and R16 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy

Abstract: The invention provides compounds of general formula (I) wherein m, n, Z1, Z2, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the specification, process for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: The invention provides compounds of general formula (I) wherein m, n, Z1, Z2, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the specification, process for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: The invention provides compounds of general formula (I) wherein Q, R, R2, R3, R4, R5, R6, R7, and R8 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: The invention provides compounds of general formula (I) wherein m, n, Q, Z1, Z2, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: The invention relates to the use of a pharmacological agent for diagnosis of OCD; Obsessive-compulsive disorder. The invention makes it possible for patients suffering from OCD to obtain a more accurate diagnosis and an indication on the intensity of the disorder.

Abstract: The invention provides compounds of general formula (I) wherein m, n, Q, Z1, Z2, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: The invention provides compounds of general formula (I), wherein R1, X, Y, n, R2, Z1, Z2, A1, A2, Q, R3, R4, R5, R6, R7, R8, t and R16 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: The invention provides compounds of general formula (I) wherein A, X, m, R1, N, R2, Z1, Z2, Q, R3, R4, R5, R6, R7, R8, t and R16 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: The present invention refers to a resilient glide for a chair's leg for minimizing the noise that normally occurs when a chair is moved along a floor. The glide comprises a flexible element with a small contact area against the floor in order to minimize friction. The flexible element comes off from a contact surface for the chair's leg arranged in a sleeve intended to surround the leg and is forming an integral part of said sleeve.

Abstract: The invention relates to the use of a composition comprising at least one substance within the group GnRH-analogues for producing a drug for treatment of obsessive-compulsive disorder (OCD). The invention makes it possible for patients suffering from OCD to obtain partial or total relief of symptoms by treatment with a composition which comprises at least one substance within the group GnRH-analogues.

Abstract: The invention provides compounds of general formula (I) wherein m, n, Q, Z1, Z2, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: The invention provides compounds of general formula (I) wherein m, n, Z1, Z2, R1, R2, R3, R4, R5, R6, R7 and R8 are as defined in the specification, process for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: The invention provides compounds of general formula (I) wherein Q, R, R1, R4, R5, R6, R7 and R8 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

Abstract: The present invention refers to a resilient glide for a chair's leg for minimizing the noise that normally occurs when a chair is moved along a floor. The glide comprises a flexible element with a small contact area against the floor in order to minimize friction. The flexible element comes off from a contact surface for the chair's leg arranged in a sleeve intended to surround the leg and is forming an integral part of said sleeve.

Abstract: The invention relates to the use of a composition comprising at least one substance within the group GnRH-analogues for producing a drug for treatment of schizophrenia. The invention makes it possible for patients suffering from schizophrenia to obtain partial or total relief of symptoms by treatment with a composition which comprises at least one substance within the group GnRH-analogues.